26 articles for K Ito
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Synthesis and antiinflammatory activity of some 2-(substituted-pyridinyl)benzimidazoles.

TBA
Discovery of Narrow Spectrum Kinase Inhibitors: New Therapeutic Agents for the Treatment of COPD and Steroid-Resistant Asthma.

Sygnature Discovery
Functional involvement of rat organic anion transporter 3 (rOat3; Slc22a8) in the renal uptake of organic anions.

University of Tokyo
Characterization of bile acid transport mediated by multidrug resistance associated protein 2 and bile salt export pump.

The University of Tokyo
Synthesis of 2-(4-substituted-1-piperazinyl)benzimidazoles as H1-antihistaminic agents.

TBA
Design and synthesis of hapten to induce phospholipase A
2-like catalytic antibody

TBA
Alteration of Na
+ permeability in human erythrocytes as studied by
23Na-NMR and inhibition of the kidney Na
+,K
+-ATPase activities with saponins: Interaction of
Gleditsia saponins with human erythrocyte membranes

TBA
Discovery of DS-9300: A Highly Potent, Selective, and Once-Daily Oral EP300/CBP Histone Acetyltransferase Inhibitor.

Daiichi Sankyo Co.
A Novel N-Substituted Valine Derivative with Unique Peroxisome Proliferator-Activated Receptor γ Binding Properties and Biological Activities.

Aix Marseille University
Discovery of Second Generation RORγ Inhibitors Composed of an Azole Scaffold.

Kyoto Prefectural University of Medicine
Charged amino acids in the transmembrane domains are involved in the determination of the substrate specificity of rat Mrp2.

The University of Tokyo
Selective inhibition of human cytochrome P450 3A4 by N-[2(R)-hydroxy-1(S)-indanyl]-5-[2(S)-(1, 1-dimethylethylaminocarbonyl)-4-[(furo[2, 3-b]pyridin-5-yl)methyl]piperazin-1-yl]-4(S)-hydroxy-2(R)-phenylmethy lpentanamide and P-glycoprotein by valspodar in gene transfectant systems.

University of Tokyo
Discovery of novel benzothienoazepine derivatives as potent inhibitors of respiratory syncytial virus.

Sygnature Discovery
TARGET SUBSTRATE PROTEIN DEGRADATION PLATFORM

University of California
Immunomodulator compounds and methods of use

Incyte
Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity

Boehringer Ingelheim International
Urease inhibitors from Indigofera gerardiana Wall.

Khyber Medical College
Oligomer-opioid agonist conjugates

Nektar Therapeutics
Proline sulfonamide derivatives as orexin receptor antagonists

Actelion Pharmaceuticals
Tetrahydropyrrolothiazine compounds

Eli Lilly
Benzodioxole piperidine compounds

Hoffmann-La Roche
Structure-based design and solid-phase parallel synthesis of phosphorylated nonpeptides to explore hydrophobic binding at the Src SH2 domain.

Ariad Pharmaceuticals
Steady-state kinetic mechanism of Ras farnesyl:protein transferase.

Merck Research Laboratories
Reaction of the molybdenum- and copper-containing carbon monoxide dehydrogenase from Oligotropha carboxydovorans with quinones.

University of California Riverside
Pharmacological characterization of the competitive GLUK5 receptor antagonist decahydroisoquinoline LY466195 in vitro and in vivo.

Eli Lilly
N-(3-lodoprop-2E-enyl)-2beta-carbomethoxy-3beta-(3',4'-dichloro phenyl)nortropane (beta-CDIT), a tropane derivative: pharmacological characterization as a specific ligand for the dopamine transporter in the rodent brain.

University of Tours